Furthermore, Cros (59) have shown that non-classical monocytes secrete high amounts of IL-1 inside a TLR signaling-dependent manner
Furthermore, Cros (59) have shown that non-classical monocytes secrete high amounts of IL-1 inside a TLR signaling-dependent manner. triggered B cells, which results in improved IgG antibody production (33, EIF4G1 34). The signaling lymphocytic activation molecule (SLAM)-family genes located downstream of will also be polymorphic. SLAM-family users are known to be essential players in relationships between B cells and T cells during the germinal center reaction (35). In mice, you will find two haplotypes of SLAM-family genes, and haplotype 2 associates with defective B-cell tolerance and the development of autoimmune disease (36). An association of a specific SLAM haplotype with human being SLE has also been reported (37). In addition to the aberrant activation of the adaptive immune system, the importance of the innate immune system is now growing for the pathogenesis of SLE since convincing susceptibility genes are implicated in not only T-/B-cell signaling but also Toll-like receptors (TLRs) and type 1 interferon signaling (38). Innate immune cells communicate TLRs that identify not only foreign nucleic acids, originating from intruding viruses and bacteria, but also self-derived nucleic acids from apoptotic cells in the sponsor body and thus may contribute to the autoimmune reactions against nuclear antigens. Accumulating evidence demonstrates PCI-24781 (Abexinostat) among several TLRs, TLR7a receptor for single-stranded RNAplays an essential role in the development of SLE. The (Y chromosome-linked autoimmune acceleration) locus, a duplication of the TLR7 gene due to a translocation of the TLR7-comprising region of the X-chromosome to the Y chromosome (39, 40), induces spontaneous lupus nephritis in male BXSB mice. Furthermore, TLR7-transgenic mice develop spontaneous lupus-like autoimmunity (41). TLR7 is an endosomal sensor and is mainly indicated on B cells and DCs. TLR7 over-expression on B cells renders RNA-reactive B cells hyper-active to produce anti-RNA auto-antibodies TLR7 activation by RNA-containing antigens taken up through RNA-specific B-cell antigen receptors (42). Besides, TLR7 over-expression on CD11c+ DCs contributes to severe lupus nephritis because of the enhanced ability of these DCs to produce chemokines, resulting in improved recruitment PCI-24781 (Abexinostat) of inflammatory monocytes into kidney lesions (43). Monocytosis is one of the unique features of SLE-prone mice. Monocytes constitute ~4% of blood leukocytes in healthy mice, whereas the rate of recurrence of monocytes is definitely 50% in aged BXSB male mice, and this age-associated monocytosis mainly consists of the Gr-1C non-classical monocyte subset (44). A earlier association study has shown that there is a remarkable correlation between monocytosis and serum levels of auto-antibodies in locus in the normal C57BL/6 (B6) background induces neither monocytosis nor lupus nephritis, in mice deficient for the inhibitory IgG Fc receptor FcRIIB, the locus induces both monocytosis and lupus nephritis (46, 47). Although FcRIIB is the major bad regulator of B cells, FcRIIB is also expressed on a wide variety of myeloid lineage cells (48). To study the cell type-specific part of FcRIIB in lupus-prone B6.FcRIIBC/C.mice, we established three strains of FcRIIB-deficient B6.mice: B-cell-specific deficiency, myeloid cell-specific deficiency and CD11c+ DC-specific deficiency. The B-cell-specific and myeloid cell-specific FcRIIB-deficient mice developed milder lupus than B6.FcRIIBC/C.mice, whereas surprisingly DC-specific deficient mice stayed disease free (47). These findings show that FcRIIB deficiency on not only B cells but also myeloid cells except DCs synergistically contributes to spontaneously happening lupus nephritis in B6.FcRIIBC/C.mice. The above three lupus-prone strains developed monocytosis. Intriguingly, in B6.FcRIIBC/C.mice and myeloid cell-specific FcRIIB-deficient B6.mice, monocytosis predominantly consisted of Gr-1C monocytes, PCI-24781 (Abexinostat) whereas in B-cell-specific FcRIIB-deficient B6.mice, monocytosis mostly consisted of PCI-24781 (Abexinostat) Gr-1+ monocytes. These observations suggest that the lack of FcRIIB manifestation on monocytes likely accelerates the FcR-mediated monocyte differentiation process PCI-24781 (Abexinostat) from your Gr-1+ subset into the Gr-1- subset (Fig. 1). Open in a separate windowpane Fig. 1. A model for the accelerated maturation of Gr-1+ monocytes into active Gr-1C monocytes in lupus-prone B6.FcRIIBC/C.mice. (A) In non-autoimmune B6.mice, monocytosis is not observed, and the differentiation process from Gr-1+ monocytes to Gr-1C monocytes is suppressed because of the negative transmission from FcRIIB. (B) In B6.FcRIIBC/C.mice, because of the lack of FcRIIB expression about monocytes, monocytosis occurs through the activation signals from IgG IC-stimulated FcRIII (CD16) and the differentiation process from Gr-1+ monocytes to Gr-1C monocytes is accelerated. These improved Gr-1C monocytes with high manifestation of CX3CR1 can be recruited into the splenic marginal zone that.